Alivus Life Sciences Ltd. NSE: ALIVUS | BSE: 543322

Mid-range Performer

Download real time

1002.95 -44.50 (-4.25%)

219.9K

NSE+BSE Volume

High vol. this week

NSE 22 Sep, 2025 3:31 PM (IST)

Alivus Life Sciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alivus Life Sciences Ltd. from all sources in a single place.

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

132 Votes:

Buy 75.0%

Sell 12.12%

Hold 12.88%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >